160 related articles for article (PubMed ID: 20363601)
21. Transitions induced by solubilized fat into reverse hexagonal mesophases.
Amar-Yuli I; Garti N
Colloids Surf B Biointerfaces; 2005 Jun; 43(2):72-82. PubMed ID: 15921902
[TBL] [Abstract][Full Text] [Related]
22. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
Milak S; Zimmer A
Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
[TBL] [Abstract][Full Text] [Related]
23. Solubilization of gabapentin into HII mesophases.
Achrai B; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
[TBL] [Abstract][Full Text] [Related]
24. Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel.
Zhang Y; Zhang K; Guo T; Li Y; Zhu C; Feng N
Int J Pharm; 2015 Feb; 479(1):219-26. PubMed ID: 25543112
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
[TBL] [Abstract][Full Text] [Related]
26. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
27. Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior.
Mishraki T; Libster D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):47-56. PubMed ID: 19748240
[TBL] [Abstract][Full Text] [Related]
28. Liquid crystalline phases and their dispersions in aqueous mixtures of glycerol monooleate and glyceryl monooleyl ether.
Popescu G; Barauskas J; Nylander T; Tiberg F
Langmuir; 2007 Jan; 23(2):496-503. PubMed ID: 17209599
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
Milak S; Chemelli A; Glatter O; Zimmer A
Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
[TBL] [Abstract][Full Text] [Related]
30. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
31. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
Sintov AC; Botner S
Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
[TBL] [Abstract][Full Text] [Related]
32. Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid.
Zhao L; Li Y; Fang L; Ren C; Xu Y; He Z
Drug Dev Ind Pharm; 2009 Jul; 35(7):814-26. PubMed ID: 19466898
[TBL] [Abstract][Full Text] [Related]
33. Anomalous phase sequences in lyotropic liquid crystals.
Lee WB; Mezzenga R; Fredrickson GH
Phys Rev Lett; 2007 Nov; 99(18):187801. PubMed ID: 17995439
[TBL] [Abstract][Full Text] [Related]
34. Modulation of physical properties of reverse hexagonal mesophases: a dielectric spectroscopy study.
Mishraki T; Ben Ishai P; Babukh D; Aserin A; Feldman Y; Garti N
J Colloid Interface Sci; 2013 Apr; 396():178-86. PubMed ID: 23415506
[TBL] [Abstract][Full Text] [Related]
35. Investigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV-Vis imaging and SAXS.
Mertz N; Bock F; Østergaard J; Yaghmur A; Weng Larsen S
Int J Pharm; 2022 Jul; 623():121880. PubMed ID: 35661744
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles.
Minghetti P; Cilurzo F; Casiraghi A; Montanari L; Fini A
J Pharm Sci; 2007 Apr; 96(4):814-23. PubMed ID: 17286288
[TBL] [Abstract][Full Text] [Related]
37. Vehicle influence on permeation through intact and compromised skin.
Gujjar M; Banga AK
Int J Pharm; 2014 Sep; 472(1-2):362-8. PubMed ID: 24979534
[TBL] [Abstract][Full Text] [Related]
38. The curvature elastic-energy function of the lipid-water cubic mesophase.
Chung H; Caffrey M
Nature; 1994 Mar; 368(6468):224-6. PubMed ID: 8145820
[TBL] [Abstract][Full Text] [Related]
39. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel.
Hosmer JM; Shin SH; Nornoo A; Zheng H; Lopes LB
J Pharm Sci; 2011 Apr; 100(4):1444-55. PubMed ID: 20957759
[TBL] [Abstract][Full Text] [Related]
40. Self-assembled nanostructured aqueous dispersions as dermal delivery systems.
Hoppel M; Caneri M; Glatter O; Valenta C
Int J Pharm; 2015 Nov; 495(1):459-462. PubMed ID: 26364712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
